Stay updated on NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial

Sign up to get notified when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision entry v3.4.3 was added to the history. Revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:55:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The history shows a new revision v3.4.2 has been added, and the prior notices and revision v3.4.1 were removed or superseded. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T05:43:28.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The site added a government funding notice banner and updated the version from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T05:34:27.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI/UIX updates to the Record History: a Show glossary option, color-coded additions/deletions, and revised revision labeling. These do not modify core study data or actionable information.
    Difference
    0.6%
    Check dated 2026-01-28T04:01:01.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page history shows a new site revision, v3.3.4, replacing v3.3.3, which is an administrative update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:57:10.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer updates include a new revision label (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure link and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:46:34.000Z thumbnail image

Stay in the know with updates to NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.